Phase 1 Trial of Tolerance and Pharmacokinetic of Chlorogenic Acid for Injection in the Advanced Malignant Tumor Subjects
Latest Information Update: 08 Aug 2022
Price :
$35 *
At a glance
- Drugs Chlorogenic acid (Primary)
- Indications Cancer; Glioma
- Focus Adverse reactions; First in man
- Sponsors Sichuan J.Z. Bio-chemical Science and Technology Development Co
- 30 Oct 2018 Status changed from recruiting to completed.
- 05 Jun 2018 Results (n=26) of recurrent high grade glioma patients, presented at the 54th Annual Meeting of the American Society of Clinical Oncology
- 01 Oct 2014 New trial record